Kringle Pharma

Drug DiscoveryJapan

Kringle Pharma, Inc. is a late-stage regenerative drug discovery bio-venture located in Shinsenrihigashimachi, Osaka, Japan. The company operates in the biotechnology and manufacturing sectors.

Subscribe to see Kringle Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Kringle Pharma at a glance

Kringle Pharma is a drug discovery company headquartered in Japan. Xcout tracks 10 named people at Kringle Pharma, including 安達喜一 (代表取締役社長).

Industry

Drug Discovery

Headquarters

Japan

Kringle Pharma leadership

安達喜一代表取締役社長
友保昌拓非常勤取締役
吉野公一郎社外取締役
土井直巳社外監査役
山口要介社外監査役
早田大真取締役

4 more named people on record for Kringle Pharma, with roles, board committees and tenure — see the full roster →

Kringle Pharma competitors

A few of Kringle Pharma's closest competitors — see the full list of competitors and alternatives →

Rege NephroDrug DiscoveryJapan

71% match

Rege Nephro Co., Ltd. is a biotechnology company headquartered at Kyoto University in Kyoto, Japan. The company engages in medical-pharmaceutical collaborative research and advanced therapeutic development for kidney and regenerative medicine.

Valuation—

Employees—

StageSeries B

Rege Nephro competitors & alternatives →

Glycomine, Inc.BiopharmaUnited States

Private

Glycomine, Inc. is a biotherapeutics company focused on developing replacement therapies and treatments for serious rare genetic diseases, operating out of major life science hubs in San Francisco and Boston.

Valuation—

Employees—

StageSeries C

Glycomine, Inc. competitors & alternatives →

iRegeneDrug DiscoveryChina

iRegene Therapeutics is a biotechnology company headquartered in Wuhan, China, with additional facilities in Suzhou. The firm specializes in regenerative medicine and advanced cell therapies designed to redefine modern medicine.

Valuation—

Employees—

StageSeries B+

iRegene competitors & alternatives →

Ensho Therapeutics, Inc.Drug DiscoveryUnited States

Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients. Founded in 2024, the company is based in Morris Plains, New Jersey.

Valuation—

Employees—

StageSeed

Ensho Therapeutics, Inc. competitors & alternatives →

PharmaResearchBiopharmaceuticalsSouth Korea

PharmaResearch is a pharmaceutical biotechnology company based on regenerative medicine, dedicated to enhancing the quality of human life and headquartered in South Korea.

Valuation—

Employees—

PharmaResearch competitors & alternatives →

KadmusBioPharmaceuticalsUnited States

Kadmus Pharmaceuticals is a pharmaceutical company headquartered in Irvine, California. The enterprise focuses on drug discovery and development within the life sciences sector.

Valuation—

Employees—

Kadmus competitors & alternatives →

Get Kringle Pharma's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Kringle Pharma at a glance

Kringle Pharma leadership

Kringle Pharma competitors

Get Kringle Pharma's news by email

Share this card

More on Kringle Pharma in Xcout Intel